RIGL
Rigel Pharmaceuticals Inc
48.10$
-1.4%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +274.3% | -27.7% | -4.5% | +25.2% | +42.0% | +87.3% | -23.3% | +2.3% | +24.2% | -2.2% | +32.6% | +37.7% | +20.6% | -27.1% | -31.8% | -14.5% | -40.7% | +52.4% | +16.8% | +6.1% | -25.2% | +51.6% | -19.8% | -12.7% | +39.9% | +213.2% | |
| – | +541.1% | -33.2% | +0.9% | +35.9% | +48.1% | +92.1% | -24.3% | +2.9% | +24.3% | -1.5% | +32.3% | +39.1% | +20.9% | -27.2% | -31.6% | -14.3% | -40.9% | +54.1% | +16.7% | -13.1% | -25.2% | +73.6% | -25.0% | -14.4% | +36.1% | +77.8% | |
| – | +740.1% | -76.6% | +131.0% | -63.7% | +9.1% | +631.6% | -37.8% | -6.8% | +3.4% | -68.0% | -39.7% | +109.9% | +79.7% | -37.7% | -27.1% | +185.8% | -59.4% | +117.2% | +99.3% | -70.5% | +34.9% | -37.8% | +29.5% | +34.0% | +73.1% | -28.5% | |
| – | +808.1% | -36.9% | -18.3% | +70.4% | +53.6% | +93.5% | -24.4% | +3.7% | +24.2% | -0.9% | +33.0% | +39.7% | +20.4% | -28.9% | -32.5% | -11.8% | -40.8% | +54.8% | +11.0% | -23.7% | -41.5% | +118.0% | -53.4% | -2.2% | +35.8% | +100.4% | |
| – | -71.8% | +73.9% | +565.9% | -83.2% | -45.7% | +161.4% | -23.9% | -68.2% | – | – | – | – | – | – | +0.0% | -96.5% | – | – | – | +148.0% | +58.0% | -3.1% | +160.6% | -24.2% | +36.2% | +24.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | – | +51.5% | +21.0% | +303.9% | +37.8% | -39.4% | +8.7% | +91.7% | |
| – | – | -9.6% | -38.3% | -31.9% | -20.6% | +22.9% | -13.9% | -13.9% | +39.3% | -35.8% | +97.9% | +7.7% | +19.3% | -23.5% | -43.7% | -35.7% | -28.3% | -24.3% | +58.5% | +55.7% | +23.9% | +344.2% | -92.8% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -7.2% | +95.3% | -8.7% | |
| – | -7.1% | +14.8% | +8.0% | -17.7% | +70.5% | +47.4% | -33.4% | +29.2% | +18.1% | -22.2% | -33.4% | +1.9% | 0.0% | -15.0% | +45.4% | +55.9% | -42.8% | -20.1% | +58.3% | +220.7% | -18.6% | +79.4% | +8.0% | -1.4% | +10.2% | -24.0% | |
| – | -15.4% | +26.1% | +41.4% | -44.0% | +41.8% | +107.1% | -52.5% | +43.4% | +49.9% | -26.4% | -36.3% | +1.8% | +5.9% | -15.7% | +36.2% | +141.0% | -33.2% | -18.8% | +51.2% | +109.9% | -29.8% | +55.6% | +2.6% | -18.3% | +18.8% | +56.8% | |
| – | +35.7% | +7.4% | +6.8% | -33.3% | -41.5% | -19.0% | +18.6% | -22.0% | +170.5% | -60.4% | -28.8% | – | – | – | – | +7.2% | +7.2% | -91.2% | – | – | +18.6% | +14.7% | -88.5% | +599.1% | -4.6% | +302.6% | |
| – | +48.8% | +48.6% | +77.3% | -60.2% | +41.1% | +28.4% | -21.6% | +120.7% | +38.5% | -47.3% | -55.5% | +10.9% | +9.1% | +130.0% | -58.7% | +71.3% | +101.3% | -52.6% | +142.5% | -35.0% | -10.7% | +2.4% | +493.1% | -68.3% | -53.2% | +115.4% | |
| – | – | -26.3% | -45.5% | -46.6% | -36.8% | +44.9% | -4.4% | -27.5% | +161.9% | -57.0% | -94.9% | -100.0% | – | – | – | – | – | – | – | – | +102.0% | +0.5% | +98.1% | +32.8% | +0.1% | -57.1% | |
| – | +6,382.8% | -40.9% | -12.1% | +57.1% | +30.8% | +107.6% | -19.7% | -5.8% | +26.7% | +5.5% | +51.2% | +42.1% | +22.4% | -28.0% | -38.4% | -28.7% | -39.8% | +82.9% | +9.2% | -51.0% | -36.8% | -10.7% | -144.8% | – | – | +11,806.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +2,219.7% | +413.4% | +22.4% | +124.6% | +58.4% | +21.1% | +14.1% | +16.0% | +24.5% | +13.5% | +28.5% | -55.4% | -31.3% | -45.8% | +0.4% | +0.9% | +6.7% | +33.8% | +27.1% | +4.3% | +0.8% | +1.0% | +1.1% | +0.9% | +1.6% | +6.5% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.